Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

IV antibacterial use for LRT infections no longer justified?

    • 2 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    IV antibacterial use for LRT infections no longer justified?. Pharmacoecon. Outcomes News 30, 11 (1995). https://doi.org/10.1007/BF03272811

    Download citation

    Keywords

    • Cephalosporin
    • Cefotaxime
    • Cefuroxime
    • Lower Respiratory Tract
    • Lower Respiratory Tract Infection